# Minocycline for the Treatment of Early-Phase Schizophrenia

> **NCT00733057** · PHASE3 · COMPLETED · sponsor: **Shalvata Mental Health Center** · enrollment: 70 (actual)

## Conditions studied

- Negative and Cognitive Symptoms in Schizophrenia

## Interventions

- **DRUG:** Minocycline
- **DRUG:** Placebo (200 mg/day)

## Key facts

- **NCT ID:** NCT00733057
- **Lead sponsor:** Shalvata Mental Health Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-08
- **Primary completion:** 2007-03
- **Final completion:** 2007-03
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2008-08-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00733057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00733057, "Minocycline for the Treatment of Early-Phase Schizophrenia". Retrieved via AI Analytics 2026-07-30 from https://api.ai-analytics.org/clinical/NCT00733057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*